NEW YORK (GenomeWeb News) – BGI has partnered with GENNET, a Prague-based center for genetics, fetal medicine, and assisted reproduction, to offer its non-invasive fetal trisomy test, NIFTY, in the Czech and Slovak Republics.

The NIFTY test uses next-generation sequencing to analyze maternal plasma for fetal aneuploidies including trisomy 21, trisomy 13, and trisomy 18, which cause Down syndrome, Patau syndrome, and Edwards syndrome, respectively.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.